Çмú´ëȸ > ÇÁ·Î±×·¥

**ÀϽÃ: 2014.5.17 (Åä)
**Àå¼Ò: ½ºÀ§Æ®È£ÅÚ ³²¿ø

 

Grand Ballroom 1 Grand Ballroom 2 Suites Hall Suites
Forum 1,3
08:20~08:50 Registration Poster
Exhibition
08:50~09:00 Opening
09:00~09:50 Session I: ¿¬±¸ºñ ¹× ÀåÇÐ±Ý ¹ßÇ¥
09:50~10:40 Session II: Á¤Ã¥°úÁ¦ °á°ú º¸°í
10:40~11:00 Coffee break
11:00~12:00 Session III: Frontier in transplantation
12:00~12:40 Session IV: Infection after transplantation
12:40~12:50 ÀÓ½ÃÃÑȸ
12:50~13:10 Break
13:10~14:00 Luncheon Symposium I
(¾Æ½ºÅÚ¶ó½º)
Luncheon Symposium III
(»ç³ëÇÇ)
Luncheon Symposium II
(Á¾±Ù´ç)
14:00~15:20 Concurrent Symposium I-1
(Management of antibody
-mediated rejection
Concurrent Symposium I-3
(Hot issues in thoracic
transplantation)
Concurrent Symposium I-2
(Viral hepatitis in liver
transplantation)
15:20~15:40 Coffee break
15:40~17:00 Concurrent Symposium II-1
(Immunosuppression in
kidney transplantation)
Concurrent Symposium II-3
(Joint session with KOTCO)
Concurrent Symposium II-2
(Interpretation of liver biopsy
in liver transplantation)
17:00~ Closing

  ³»¿ë ÁÂÀå/¿¬ÀÚ
08:20~08:50 Registration
08:50~09:00 Opening ÇÑ´öÁ¾(¿ï»êÀÇ´ë, ´ëÇÑÀ̽ÄÇÐȸ ȸÀå)
09:00~09:50 Session I: ¿¬±¸ºñ ¹× ÀåÇÐ±Ý ¹ßÇ¥ ÁÂÀå: Çã   ±æ(ºÀ»ýº´¿ø)
¼­°æ¼®(¼­¿ïÀÇ´ë)
09:00~09:15 À̽ĽŠ°èȹ»ý°Ë ¹× Àç»ý°Ë¿¡¼­ kidney injury molecule-1 ÀÇ Ç¥Çö Á¤ÇöÁÖ(¿¬¼¼ÀÇ´ë)
09:15~09:30 ¼±Ãµ¼º ´ãµµ Æó¼âÁõ ȯ¾Æ¿¡¼­ ¸»ÃÊÇ÷¾×¿¡ Á¸ÀçÇÏ´Â ¸ðÀÚ°£ microchimerism¿¡
°üÇÑ ¿¬±¸
À̳²ÁØ(¼­¿ïÀÇ´ë)
09:30~09:45 Recurrence of Hepatocellular Carcinoma - Importance of mRECIST Response to Chemoembolization and Tumor Size after LT and Mayo clinic Protocol Review ±èµÎÁø(ÇѸ²ÀÇ´ë)
09:50~10:40 Session II: Á¤Ã¥°úÁ¦ °á°ú º¸°í ÁÂÀå: À̼®±¸(¼º±Õ°üÀÇ´ë)
Á¤»ó¿µ(Àü³²ÀÇ´ë)
09:50~10:05 Second report from the Korean Organ Transplantation Registry (KOTRY) ¾È±Ô¸®(¼­¿ïÀÇ´ë)
10:05~10:15 ÀÌ½Ä ±â¼ú R&D »ç¾÷ ±âȹ º¸°í ±è¼ºÁÖ(¼º±Õ°üÀÇ´ë)
10:15~10:30 ´ëÇÑÀ̽ÄÇÐȸ Á¤Ã¥°úÁ¦ ÃÖÁ¾º¸°í; Çѱ¹Çü MELD System °³¹ß;
°£ÀÌ½Ä ´ë±âÀÚÀÇ »ýÁ¸ºÐ¼®
±è¸í¼ö(¿¬¼¼ÀÇ´ë)
10:30~10:40 KODA ÁøÇຸ°í ÇÏÁ¾¿ø(¼­¿ïÀÇ´ë)
10:40~11:00 Coffee Break
11:00~12:00 Session III: Frontier in transplantation ÁÂÀå: ±èµ¿±¸(°¡Å縯ÀÇ´ë)
±èÀ¯¼±(¿¬¼¼ÀÇ´ë)
11:00~11:20 Simultaneous bone marrow and kidney transplantation ¹ÚÀç¹ü(¼º±Õ°üÀÇ´ë)
11:20~11:40 º¹ºÎ ´ÙÀå±â ÀÌ½Ä ±è´ë¿¬(¿ï»êÀÇ´ë)
11:40~12:00 Ç÷°ü¼º º¹ÇÕ Á¶Á÷ À̽ļú ¿ì»óÇö(´õºíÀ¯º´¿ø)
12:00~12:40 Session IV: Infection after transplantation ÁÂÀå: ¹®Àμº(°¡Å縯ÀÇ´ë)
±è¼ºÁÖ(¼º±Õ°üÀÇ´ë)
12:00~12:20 Update on vaccination for transplant candidates and recipients ±è»óÀÏ(°¡Å縯ÀÇ´ë)
12:20~12:40 Infection prevention in solid organ transplant recipients ¹é°æ¶õ(¼º±Õ°üÀÇ´ë)
12:40~12:50 ÀÓ½ÃÃÑȸ
12:50~13:10 Break
13:10~14:00 Luncheon Symposium(¾Æ½ºÅÚ¶ó½º/Á¾±Ù´ç/»ç³ëÇÇ)
14:00~15:20 Concurrent Symposium I-1: Management of antibody-mediated rejection ÁÂÀå: Á¶È«·¡(¿ï»ê´ëº´¿ø)
¾çö¿ì(°¡Å縯ÀÇ´ë)
14:00~14:20 Banff 2013 Meeting Report: Related to Antibody-Mediated Rejection ±è¿ëÁø(¿µ³²ÀÇ´ë)
14:20- 14:40 Clinical Impact of Microcirculation Inflammation in Renal Allograft Tissue Çã±ÔÇÏ(¿¬¼¼ÀÇ´ë)
14:40~15:00 Impact of Non-HLA Antibodies on Antibody-Mediated Rejection ÀÌ   ½Ä(ÀüºÏÀÇ´ë)
15:00~15:20 What's new in the treatment of chronic antibody mediated rejection? Á¤º´ÇÏ(°¡Å縯ÀÇ´ë)
14:00~15:20 Concurrent Symposium I-2: Viral hepatitis in liver transplantation ÁÂÀå: ±è¼øÀÏ(¿¬¼¼ÀÇ´ë)
Á¶Àç¿ø(¼º±Õ°üÀÇ´ë)
14:00~14:26 New horizon of HCV management ±èµµ¿µ(¿¬¼¼ÀÇ´ë)
14:26~14:52 Emerging role of nucleos(t)ide in post-LT management of HBV À̱¤¿õ(¼­¿ïÀÇ´ë)
14:52~15:18 °£ÀÌ½Ä ÈÄ ¹ß»ýÇϴ Ȳ´ÞÀÇ ÀÓ»ó°æ°ú¿Í Ä¡·á ÃÖÁ¾¿µ(°¡Å縯ÀÇ´ë)
14:00~15:20 Concurrent Symposium I-3 : Hot issues in thoracic transplantation ÁÂÀå: ¹éȿä(¿¬¼¼ÀÇ´ë)
±èÀçÁß(¿ï»êÀÇ´ë)
14:00~14:26 Diagnosis and Treatment of Antibody Mediated Rejection After Heart Transplantation ±èÀçÁß(¿ï»êÀÇ´ë)
14:26~14:52 Role of mTOR inhibitor in heart transplantation ÀÌÇØ¿µ(¼­¿ïÀÇ´ë)
14:52~15:18 Evaluation of infections in the lung transplant patients ¹Ú¹«¼®(¿¬¼¼ÀÇ´ë)
15:20~15:40 Coffee Break
15:40~17:00 Concurrent Symposium II-1: Immunosuppression in kidney transplantation ÁÂÀå: ¹Ú¼ö±æ(¿ï»êÀÇ´ë)
±Ç¿ÀÁ¤(ÇѾçÀÇ´ë)
15:40~16:00 Current status of steroid/CNI withdrawal Çã¿ì¼º(¼º±Õ°üÀÇ´ë)
16:00~16:20 Immunosuppression in pregnancy and lactation ±èÁöÀÏ(°¡Å縯ÀÇ´ë)
16:20~16:40 Immunosuppression in pediatric patients ¹Î»óÀÏ(¼­¿ïÀÇ´ë)
16:40~17:00 New immunosuppressants in pipeline ¼ºÀº¿µ(ºÎ»êÀÇ´ë)
15:40~17:00 Concurrent Symposium II-2: Interpretation of liver biopsy in liver transplantation ÁÂÀå: °­±¸Á¤(°è¸íÀÇ´ë)
À¯Èñö(ÀüºÏÀÇ´ë)
15:40~16:06 Histological diagnosis of acute cellular rejection in liver transplantation Á¤Àº¼±(°¡Å縯ÀÇ´ë)
16:06~16:32 Differential diagnosis of HCV recurrence and rejection ÀÌ°æºÐ(¼­¿ïÀÇ´ë)
16:32~16:58 Various histologic findings of late allograft dysfunction after liver transplantation ±èÇý·É(¼­¿ïÀÇ´ë)
15:40~17:00 Concurrent Symposium II-3: Joint session with KOTCO ÁÂÀå: Á¶¿øÇö(°è¸íÀÇ´ë)
±èº¹³à(»ï¼º¼­¿ïº´¿ø)
15:40~16:00 Current problems and solutions for deceased donor organ donation in the real field Àü°æ¿Á(¼¼ºê¶õ½ºº´¿ø)
16:00~16:30 Donor derived disease transmission in transplantation ÇÏ¿µÀº(¼º±Õ°üÀÇ´ë)
16:30~17:00 Immunologic tests for organ transplantation ¹Ú¸íÈñ(Çѱ¹Àå±â±âÁõ¿ø)
17:00~ Closing